We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+0.24%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.6B
AUM Growth
+$1.47B
(+9.1%)
Cap. Flow
+$1.6B
Cap. Flow
% of AUM
9.12%
Top 10 Holdings %
Top 10 Hldgs %
17.57%
Holding
1,695
New
602
Increased
310
Reduced
364
Closed
414
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$207M |
| 2 |
Pfizer
PFE
|
+$171M |
| 3 |
Johnson & Johnson
JNJ
|
+$140M |
| 4 |
SS&C Technologies
SSNC
|
+$132M |
| 5 |
Microsoft
MSFT
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$158M |
| 2 |
Meta Platforms (Facebook)
META
|
+$120M |
| 3 |
Booking.com
BKNG
|
+$106M |
| 4 |
Merck
MRK
|
+$93.9M |
| 5 |
Idexx Laboratories
IDXX
|
+$92.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.54% |
| 2 | Technology | 21.21% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Industrials | 12.45% |
| 5 | Financials | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHL
1101
DELISTED
China Mobile Limited
CHL
| $75K | ﹤0.01% |
+1,810
| New | +$77.1K |
|
1102
Assembly Biosciences
ASMB
$529M
| $74K | ﹤0.01% |
+626
| New | +$94.7K |
|
|
CHX
1103
DELISTED
ChampionX
CHX
| $74K | ﹤0.01% |
+2,737
| New | +$79.9K |
|
1104
TechnipFMC
FTI
$27.3B
| $74K | ﹤0.01% |
4,095
-69,602
| -94% | -$1.3M |
|
1105
Century Casinos
CNTY
$34M
| $73K | ﹤0.01% |
+9,511
| New | +$82.8K |
|
1106
Innospec
IOSP
$2.28B
| $73K | ﹤0.01% |
+817
| New | +$73.2K |
|
1107
NETGEAR
NTGR
$635M
| $73K | ﹤0.01% |
2,263
-72,112
| -97% | -$2.26M |
|
1108
Sally Beauty Holdings
SBH
$1.58B
| $73K | ﹤0.01% |
+4,877
| New | +$63.8K |
|
|
CATM
1109
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $73K | ﹤0.01% |
+2,391
| New | +$70.7K |
|
|
AVX
1110
DELISTED
AVX Corporation
AVX
| $73K | ﹤0.01% |
4,803
-13,501
| -74% | -$204K |
|
1111
PennyMac Financial
PFSI
$4.02B
| $70K | ﹤0.01% |
+2,312
| New | +$62.4K |
|
|
UBX
1112
DELISTED
Unity Biotechnology
UBX
| $70K | ﹤0.01% |
+1,143
| New | +$80.9K |
|
1113
Hilton Grand Vacations
HGV
$3.55B
| $69K | ﹤0.01% |
+2,160
| New | +$67.9K |
|
1114
Minerals Technologies
MTX
$2.34B
| $69K | ﹤0.01% |
+1,303
| New | +$66.8K |
|
1115
Prestige Consumer Healthcare
PBH
$2.6B
| $69K | ﹤0.01% |
+1,992
| New | +$65.6K |
|
1116
Franco-Nevada
FNV
$46B
| $67K | ﹤0.01% |
740
-26,660
| -97% | -$2.44M |
|
1117
Garrett Motion
GTX
$5.57B
| $67K | ﹤0.01% |
+6,759
| New | +$83.1K |
|
1118
Insight Enterprises
NSIT
$4.38B
| $67K | ﹤0.01% |
+1,204
| New | +$63.7K |
|
1119
Sasol
SSL
$7.1B
| $67K | ﹤0.01% |
+3,947
| New | +$80.4K |
|
1120
Eldorado Gold
EGO
$9.89B
| $66K | ﹤0.01% |
+8,500
| New | +$69.1K |
|
|
GTLS
1121
DELISTED
Chart Industries
GTLS
| $66K | ﹤0.01% |
1,051
-42,881
| -98% | -$2.9M |
|
1122
Gaia
GAIA
$48.4M
| $65K | ﹤0.01% |
+9,934
| New | +$70K |
|
|
NWHM
1123
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $65K | ﹤0.01% |
+15,005
| New | +$61.6K |
|
1124
Gates Industrial Corporation Ltd.
GTES
$7.15B
| $64K | ﹤0.01% |
6,325
-197,281
| -97% | -$1.94M |
|
1125
Omnicell
OMCL
$1.68B
| $64K | ﹤0.01% |
+883
| New | +$64.8K |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q3 2019 Portfolio in Review
As of Q3 2019, Marshall Wace North America held 1,695 positions worth $17.6B, up 9.1% from $16.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Marshall Wace North America deployed $1.6B of net new capital in Q3 2019, opening 602 new positions and adding to 310 existing holdings. Its largest new stake was Johnson & Johnson: 1,065,531 shares worth $138M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $120M trimmed.
- Marshall Wace North America's largest Q3 2019 buy was Johnson & Johnson: 1,065,531 shares worth $138M.
- Marshall Wace North America added most to Apple in Q3 2019, an estimated $207M increase.
- Marshall Wace North America's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $120M.
- Marshall Wace North America fully exited Abbott in Q3 2019, selling an estimated $158M.
- Marshall Wace North America's ten largest holdings make up 18% of its $17.6B portfolio in Q3 2019.
- Marshall Wace North America opened 602 new positions and closed 414 in Q3 2019.
- Marshall Wace North America's portfolio value rose 9.1% quarter-over-quarter to $17.6B.
Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.